75 related articles for article (PubMed ID: 1362951)
21. Metabolism of the antimammary cancer antiestrogenic agent tamoxifen. II. Flavin-containing monooxygenase-mediated N-oxidation.
Mani C; Hodgson E; Kupfer D
Drug Metab Dispos; 1993; 21(4):657-61. PubMed ID: 8104125
[TBL] [Abstract][Full Text] [Related]
22. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
Beland FA
Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
[TBL] [Abstract][Full Text] [Related]
23. Oxidation of 1,8-cineole, the monoterpene cyclic ether originated from eucalyptus polybractea, by cytochrome P450 3A enzymes in rat and human liver microsomes.
Miyazawa M; Shindo M; Shimada T
Drug Metab Dispos; 2001 Feb; 29(2):200-5. PubMed ID: 11159812
[TBL] [Abstract][Full Text] [Related]
24. Influence of inducers and inhibitors on the metabolism in vitro and neurochemical effects in vivo of MDMA.
Gollamudi R; Ali SF; Lipe G; Newport G; Webb P; Lopez M; Leakey JE; Kolta M; Slikker W
Neurotoxicology; 1989; 10(3):455-66. PubMed ID: 2576302
[TBL] [Abstract][Full Text] [Related]
25. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats.
Kumagai Y; Lin LY; Hiratsuka A; Narimatsu S; Suzuki T; Yamada H; Oguri K; Yoshimura H; Cho AK
Mol Pharmacol; 1994 Feb; 45(2):359-65. PubMed ID: 7906857
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of oxidative drug metabolism by orphenadrine: in vitro and in vivo evidence for isozyme-specific complexation of cytochrome P-450 and inhibition kinetics.
Reidy GF; Mehta I; Murray M
Mol Pharmacol; 1989 May; 35(5):736-43. PubMed ID: 2725477
[TBL] [Abstract][Full Text] [Related]
27. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
[TBL] [Abstract][Full Text] [Related]
28. Immunochemical detection and quantitation of microsomal cytochrome P-450 and reduced nicotinamide adenine dinucleotide phosphate:cytochrome P-450 reductase in the rat ventral prostate.
Haaparanta T; Halpert J; Glaumann H; Gustafsson JA
Cancer Res; 1983 Nov; 43(11):5131-7. PubMed ID: 6413054
[TBL] [Abstract][Full Text] [Related]
29. The continuous kinetic determination of p-nitroanisole O-demethylation in hemoglobin-free perfused rat liver.
Thurman RG; Marazzo DP; Jones LS; Kauffman FC
J Pharmacol Exp Ther; 1977 May; 201(2):498-506. PubMed ID: 870683
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and efficacy of structurally related spirohydantoin and spirosuccinimide aldose reductase inhibitors.
Park YH; Barker R; Griffin B; Barratt D; DuPriest M; Brazzell K; York B; Mayer P
Xenobiotica; 1992 May; 22(5):543-50. PubMed ID: 1413869
[TBL] [Abstract][Full Text] [Related]
31. Biotransformation of coumarin derivatives (1). 7-alkoxycoumarin O-dealkylase in liver microsomes.
Matsubara T; Yoshihara E; Iwata T; Tochino Y; Hachino Y
Jpn J Pharmacol; 1982 Feb; 32(1):9-21. PubMed ID: 6979650
[TBL] [Abstract][Full Text] [Related]
32. [Stereoselectivity in O-demethylation of trans tramadol in rat liver microsomes in vitro].
Wang N; Liu HC; Liu CS; Hou YN
Yao Xue Xue Bao; 2002 Mar; 37(3):169-74. PubMed ID: 12579754
[TBL] [Abstract][Full Text] [Related]
33. Rabbit hepatic microsomal O-demethylation of chlorotrianisene.
Ruenitz PC
Drug Metab Dispos; 1978; 6(6):631-6. PubMed ID: 33024
[TBL] [Abstract][Full Text] [Related]
34. Metabolism of tiaramide in vitro. I. Oxidative metabolism of tiaramide by human and rat liver microsomes.
Iwasaki K; Noguchi H; Kamataki T; Kato R
Xenobiotica; 1982 Apr; 12(4):221-6. PubMed ID: 7113258
[TBL] [Abstract][Full Text] [Related]
35. Interspecies Variation in NCMN
Dai Z; Sun G; Yang J; Hou J; Zhou P; Xie W; Ge G; Sun X; Yang L
Molecules; 2019 Jul; 24(15):. PubMed ID: 31366067
[TBL] [Abstract][Full Text] [Related]
36. Characterization of oxidative and reductive metabolism in vitro of nitrofluoranthenes by rat liver enzymes.
Belisario MA; Pecce R; Della Morte R; Arena AR; Cecinato A; Ciccioli P; Staiano N
Carcinogenesis; 1990 Feb; 11(2):213-8. PubMed ID: 2302747
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the pharmacokinetics and pharmacodynamics of the aldose reductase inhibitors, AL03152 (RS), AL03802 (R), and AL03803 (S).
Park YH; Mayer PR; Barker R; DuPriest M; Griffin BW; Williams GW; York BM; Slattery JT
Pharm Res; 1993 Apr; 10(4):593-7. PubMed ID: 8483844
[TBL] [Abstract][Full Text] [Related]
38. Interspecies comparison of the pharmacokinetics of aldose reductase inhibitors.
Brazzell RK; Park YH; Wooldridge CB; McCue B; Barker R; Couch R; York B
Drug Metab Dispos; 1990; 18(4):435-40. PubMed ID: 1976064
[TBL] [Abstract][Full Text] [Related]
39. [Stereoselective N-demethylation of chlorpheniramine in rat liver microsomes: studies on age and sex differences].
Nomura A; Sakurai E; Hikichi N
Yakugaku Zasshi; 1995 Aug; 115(8):633-40. PubMed ID: 7473061
[TBL] [Abstract][Full Text] [Related]
40. Oxidation of carbovir, a carbocyclic nucleoside, by rat liver cytosolic enzymes. Enantioselectivity and enantiomeric inhibition.
Patanella JE; Walsh JS
Drug Metab Dispos; 1992; 20(6):912-9. PubMed ID: 1362946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
